A urokinase-derived peptide (A6) increases survival of mice bearing orthotopically grown prostate cancer and reduces lymph node metastasis.

MLA

Boyd, Douglas D., et al. “A Urokinase-Derived Peptide (A6) Increases Survival of Mice Bearing Orthotopically Grown Prostate Cancer and Reduces Lymph Node Metastasis.” The American Journal of Pathology, vol. 162, no. 2, Feb. 2003, pp. 619–26. EBSCOhost, https://doi.org/10.1016/S0002-9440(10)63855-2.

APA

Boyd, D. D., Kim, S.-J., Wang, H., Jones, T. R., & Gallick, G. E. (2003). A urokinase-derived peptide (A6) increases survival of mice bearing orthotopically grown prostate cancer and reduces lymph node metastasis. The American Journal of Pathology, 162(2), 619–626. https://doi.org/10.1016/S0002-9440(10)63855-2

Chicago

Boyd, Douglas D, Sun-Jin Kim, Heng Wang, Terence R Jones, and Gary E Gallick. 2003. “A Urokinase-Derived Peptide (A6) Increases Survival of Mice Bearing Orthotopically Grown Prostate Cancer and Reduces Lymph Node Metastasis.” The American Journal of Pathology 162 (2): 619–26. doi:10.1016/S0002-9440(10)63855-2.